RCA
RDY icon

Resonant Capital Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Resonant Capital Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,526
Closed -$146K – 567
2026
Q1 		$146K Buy
+10,526
New +$147K 0.01% 482
2025
Q4 		– Sell
-15,006
Closed -$210K – 465
2025
Q3 		$210K Buy
+15,006
New +$216K 0.01% 415

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
AIM
ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

Resonant Capital Advisors's RDY Position: Q2 2026 in Review

Resonant Capital Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 10,526 shares — an estimated $146K sold.

Resonant Capital Advisors first reported a position in RDY in Q3 2025 and held it in 2 quarters. The position peaked at $210K in Q3 2025. 101 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Resonant Capital Advisors reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
  • Resonant Capital Advisors sold 10,526 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $146K.
  • Resonant Capital Advisors first reported a position in Dr. Reddy's Laboratories in Q3 2025 and held it in 2 quarters.
  • Resonant Capital Advisors's Dr. Reddy's Laboratories position peaked at $210K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.